Mackenzie Financial’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $798K | Buy |
139,207
+96,602
| +227% | +$554K | ﹤0.01% | 1076 |
|
|
2025
Q1 | $348K | Buy |
42,605
+20,107
| +89% | +$164K | ﹤0.01% | 1330 |
|
|
2024
Q4 | $212K | Sell |
22,498
-6,379
| -22% | -$60.1K | ﹤0.01% | 1543 |
|
|
2024
Q3 | $308K | Buy |
28,877
+1,678
| +6% | +$17.9K | ﹤0.01% | 1172 |
|
|
2024
Q2 | $270K | Buy |
27,199
+191
| +0.7% | +$1.9K | ﹤0.01% | 1208 |
|
|
2024
Q1 | $318K | Sell |
27,008
-2,049
| -7% | -$24.1K | ﹤0.01% | 1148 |
|
|
2023
Q4 | $412K | Buy |
29,057
+4,260
| +17% | +$60.4K | ﹤0.01% | 1053 |
|
|
2023
Q3 | $274K | Sell |
24,797
-18,672
| -43% | -$206K | ﹤0.01% | 1169 |
|
|
2023
Q2 | $534K | Sell |
43,469
-7,711
| -15% | -$94.8K | ﹤0.01% | 998 |
|
|
2023
Q1 | $568K | Buy |
51,180
+8,490
| +20% | +$94.2K | ﹤0.01% | 987 |
|
|
2022
Q4 | $521K | Sell |
42,690
-14,561
| -25% | -$178K | ﹤0.01% | 915 |
|
|
2022
Q3 | $598K | Sell |
57,251
-21,376
| -27% | -$223K | ﹤0.01% | 893 |
|
|
2022
Q2 | $844K | Buy |
78,627
+20,750
| +36% | +$223K | ﹤0.01% | 860 |
|
|
2022
Q1 | $548K | Sell |
57,877
-332
| -0.6% | -$3.14K | ﹤0.01% | 973 |
|
|
2021
Q4 | $672K | Sell |
58,209
-1,026
| -2% | -$11.8K | ﹤0.01% | 957 |
|
|
2021
Q3 | $566K | Buy |
59,235
+6,513
| +12% | +$62.2K | ﹤0.01% | 979 |
|
|
2021
Q2 | $508K | Buy |
52,722
+16,046
| +44% | +$155K | ﹤0.01% | 973 |
|
|
2021
Q1 | $362K | Buy |
36,676
+17,105
| +87% | +$169K | ﹤0.01% | 996 |
|
|
2020
Q4 | $452K | Sell |
19,571
-39,714
| -67% | -$917K | ﹤0.01% | 858 |
|
|
2020
Q3 | $837K | Buy |
59,285
+17,460
| +42% | +$247K | ﹤0.01% | 702 |
|
|
2020
Q2 | $631K | Buy |
+41,825
| New | +$631K | ﹤0.01% | 759 |
|